BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19158668)

  • 1. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
    Bertran-Gonzalez J; Håkansson K; Borgkvist A; Irinopoulou T; Brami-Cherrier K; Usiello A; Greengard P; Hervé D; Girault JA; Valjent E; Fisone G
    Neuropsychopharmacology; 2009 Jun; 34(7):1710-20. PubMed ID: 19158668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol.
    Bertran-Gonzalez J; Bosch C; Maroteaux M; Matamales M; Hervé D; Valjent E; Girault JA
    J Neurosci; 2008 May; 28(22):5671-85. PubMed ID: 18509028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons.
    Dell'anno MT; Pallottino S; Fisone G
    Neuropharmacology; 2013 Mar; 66():179-86. PubMed ID: 22507666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.
    Bonito-Oliva A; Pallottino S; Bertran-Gonzalez J; Girault JA; Valjent E; Fisone G
    Neuropharmacology; 2013 Sep; 72():197-203. PubMed ID: 23643747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol-induced Nur77 expression in striatopallidal neurons is under the control of protein phosphatase 1 regulation by DARPP-32.
    Sánchez N; Coura R; Engmann O; Marion-Poll L; Longueville S; Hervé D; Andrés ME; Girault JA
    Neuropharmacology; 2014 Apr; 79():559-66. PubMed ID: 24440754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKA-dependent phosphorylation of ribosomal protein S6 does not correlate with translation efficiency in striatonigral and striatopallidal medium-sized spiny neurons.
    Biever A; Puighermanal E; Nishi A; David A; Panciatici C; Longueville S; Xirodimas D; Gangarossa G; Meyuhas O; Hervé D; Girault JA; Valjent E
    J Neurosci; 2015 Mar; 35(10):4113-30. PubMed ID: 25762659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice.
    Santini E; Alcacer C; Cacciatore S; Heiman M; Hervé D; Greengard P; Girault JA; Valjent E; Fisone G
    J Neurochem; 2009 Feb; 108(3):621-33. PubMed ID: 19187092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons.
    Rapanelli M; Frick LR; Horn KD; Schwarcz RC; Pogorelov V; Nairn AC; Pittenger C
    J Biol Chem; 2016 Sep; 291(40):21042-21052. PubMed ID: 27510032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32.
    Valjent E; Bertran-Gonzalez J; Bowling H; Lopez S; Santini E; Matamales M; Bonito-Oliva A; Hervé D; Hoeffer C; Klann E; Girault JA; Fisone G
    Neuropsychopharmacology; 2011 Nov; 36(12):2561-70. PubMed ID: 21814187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors.
    Håkansson K; Galdi S; Hendrick J; Snyder G; Greengard P; Fisone G
    J Neurochem; 2006 Jan; 96(2):482-8. PubMed ID: 16336634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum.
    Yabuuchi K; Kuroiwa M; Shuto T; Sotogaku N; Snyder GL; Higashi H; Tanaka M; Greengard P; Nishi A
    Neuroscience; 2006 Aug; 141(1):19-25. PubMed ID: 16750892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
    Hara M; Fukui R; Hieda E; Kuroiwa M; Bateup HS; Kano T; Greengard P; Nishi A
    J Neurochem; 2010 May; 113(4):1046-59. PubMed ID: 20236221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the phosphorylation of Trimethyl-lysine27 histone H3 at serine 28 in distinct populations of striatal projection neurons.
    Bonito-Oliva A; Södersten E; Spigolon G; Hu X; Hellysaz A; Falconi A; Gomes AL; Broberger C; Hansen K; Fisone G
    Neuropharmacology; 2016 Aug; 107():89-99. PubMed ID: 26947946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons.
    Farrell MS; Pei Y; Wan Y; Yadav PN; Daigle TL; Urban DJ; Lee HM; Sciaky N; Simmons A; Nonneman RJ; Huang XP; Hufeisen SJ; Guettier JM; Moy SS; Wess J; Caron MG; Calakos N; Roth BL
    Neuropsychopharmacology; 2013 Apr; 38(5):854-62. PubMed ID: 23303063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal Distribution and Cytoarchitecture of Dopamine Receptor Subtype 1 and 2: Evidence from Double-Labeling Transgenic Mice.
    Ren K; Guo B; Dai C; Yao H; Sun T; Liu X; Bai Z; Wang W; Wu S
    Front Neural Circuits; 2017; 11():57. PubMed ID: 28860974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum.
    Gangarossa G; Perroy J; Valjent E
    Brain Struct Funct; 2013 Mar; 218(2):405-19. PubMed ID: 22453353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
    Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
    Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
    Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G
    Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.